CD8A and neoplasm: In mouse tumor microenvironments, similar to those in the LCMV Cl13 model, CD8+ T cells in the early phase (day 8) exhibit reversible impairment, whereas CD8+ T cells in the late phase (day 35) exhibit irreversible dysfunction from which they cannot be rescued.26